Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation

Completed · Phase 3

Conditions studied: Trauma Injury

In brief

The purpose of this trial is to compare standard of care (SOC) massive transfusion protocol to SOC massive transfusion protocol plus early use of cryoprecipitate (within 90 minutes of emergency department arrival).

Key facts

Study ID
NCT04704869
Run by
Bryan Cotton
People needed
1604
Starts
2017-01-01
Expected to finish
2022-11-01
Last updated by the study team
2025-01-14

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.